• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数据删失对胸部损伤风险曲线的影响。

Effect of data censoring on thoracic injury risk curves.

作者信息

Albert Devon L, Hardy Warren N, Kemper Andrew R

机构信息

Center for Injury Biomechanics, Virginia Tech, Blacksburg, Virginia.

出版信息

Traffic Inj Prev. 2024;25(sup1):S33-S42. doi: 10.1080/15389588.2024.2405643. Epub 2024 Nov 1.

DOI:10.1080/15389588.2024.2405643
PMID:39485709
Abstract

OBJECTIVE

The first objective was to evaluate the effect of using less censored (i.e., exact and interval-censored) data on thoracic injury risk curves and the resulting injury probabilities. The second objective was to generate new injury risk curves to predict Abbreviated Injury Scale (AIS) 3+ rib fractures based on chest deflection.

METHODS

Two data sets consisting of postmortem human surrogate (PMHS) tests with multipoint chest deflection measurements were compiled: A less censored data set consisting of exact and interval-censored data and a doubly censored data set consisting of left- and right-censored data. Chest deflection data from both data sets were processed in a consistent manner to calculate the maximum deflections at different locations across the chest. Survival analysis methods were used to generate nonparametric and parametric injury risk curves for serious skeletal injury. The total sample sizes and proportions of less censored data used to generate the risk curves were varied for each curve to evaluate the effects of sample size and less censored data on risk curve shape and predicted injury thresholds.

RESULTS

Increasing the proportion of less censored data resulted in steeper injury risk curves and a higher predicted risk for a given amount of deflection. Differences in injury risk were more pronounced in the upper half of the injury risk curves. Introducing less censored data also produced narrower confidence intervals. At a total sample size of 79, increasing the percentage of less censored data from 0 to 30 had minimal effect on the shape of the risk curve.

CONCLUSIONS

Doubly censored chest deflection data have historically been used to generate thoracic injury risk curves for frontal motor vehicle crash events. This study found that incorporating less censored data into thoracic injury risk curves meaningfully affected the shape of the injury risk curves and their resulting injury risk predictions. All of the injury risk curves generated in the study predicted a lower threshold for serious rib fracture injury compared to previously developed injury risks curves that are currently in use in the field. Based on the results of this study, adding less censored data to injury risk curves should be strongly considered to improve thoracic injury risk curve prediction and confidence, especially for smaller sample sizes.

摘要

目的

首先,评估使用较少受删失数据(即精确和区间删失数据)对胸伤风险曲线和由此产生的损伤概率的影响。第二个目的是生成新的损伤风险曲线,以基于胸部挠度预测 Abbreviated Injury Scale(AIS)3+肋骨骨折。

方法

编译了包含多点胸部挠度测量的死后人体替代物(PMHS)测试的两个数据集:一个包含精确和区间删失数据的较少删失数据集,以及一个由左右删失数据组成的双重删失数据集。使用生存分析方法为严重骨骼损伤生成非参数和参数损伤风险曲线。为每条曲线生成风险曲线的总样本量和较少删失数据的比例有所不同,以评估样本量和较少删失数据对风险曲线形状和预测损伤阈值的影响。

结果

增加较少删失数据的比例导致损伤风险曲线更加陡峭,并且在给定挠度下预测的风险更高。在上半部分的损伤风险曲线上,损伤风险的差异更为明显。引入较少删失数据还产生了更窄的置信区间。在总样本量为 79 的情况下,将较少删失数据的百分比从 0 增加到 30 对风险曲线的形状几乎没有影响。

结论

胸部挠度的双重删失数据历来被用于生成正面汽车碰撞事件的胸部损伤风险曲线。本研究发现,将较少删失数据纳入到胸伤风险曲线中,会显著影响损伤风险曲线的形状及其由此产生的损伤风险预测。与目前在该领域使用的先前开发的损伤风险曲线相比,研究中生成的所有损伤风险曲线都预测出了较低的严重肋骨骨折损伤阈值。基于本研究的结果,应强烈考虑将较少删失数据添加到损伤风险曲线中,以提高胸伤风险曲线预测的准确性和置信度,尤其是在较小的样本量情况下。

相似文献

1
Effect of data censoring on thoracic injury risk curves.数据删失对胸部损伤风险曲线的影响。
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
7
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
8
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.
9
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.